Martin Schlapschy Selected Research

Immunoglobulin Fab Fragments

4/2020	First In-Human Medical Imaging with a PASylated 89Zr-Labeled Anti-HER2 Fab-Fragment in a Patient with Metastatic Breast Cancer.
1/2015	High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation.
12/2004	Functional humanization of an anti-CD30 Fab fragment for the immunotherapy of Hodgkin's lymphoma using an in vitro evolution approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Schlapschy Research Topics

Disease

5	Neoplasms (Cancer) 07/2021 - 07/2012
3	Body Weight (Weight, Body) 10/2016 - 05/2015
2	Inflammation (Inflammations) 01/2020 - 01/2018
2	Infections 01/2019 - 01/2018
2	Obesity 10/2016 - 01/2016
2	Hodgkin Disease (Hodgkin's Disease) 03/2009 - 12/2004
1	Breast Neoplasms (Breast Cancer) 04/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Peritonitis 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019
1	Chronic Hepatitis B 01/2019
1	Viremia 01/2018
1	Disease Progression 01/2018
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 10/2016
1	Hyperphagia (Overeating) 10/2016
1	Lipodystrophy 01/2016
1	Insulin Resistance 01/2016
1	Hypothermia 01/2016
1	Weight Loss (Weight Reduction) 01/2016
1	Encephalomyelitis (Myeloencephalitis) 10/2014
1	Multiple Sclerosis 10/2014
1	Cardiac Arrhythmias (Arrythmia) 09/2012
1	Ascites 07/2012

Drug/Important Bio-Agent (IBA)

4	LeptinIBA 10/2016 - 05/2015
3	Immunoglobulin Fab FragmentsIBA 04/2020 - 12/2004
2	Monoclonal AntibodiesIBA 07/2021 - 03/2009
2	LipidsIBA 07/2021 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 07/2021 - 10/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2018
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020 - 01/2018
2	Interleukin-8 (Interleukin 8)IBA 01/2020 - 01/2018
2	CytokinesIBA 01/2020 - 01/2018
2	InterferonsIBA 01/2019 - 01/2018
1	Tumor Biomarkers (Tumor Markers)IBA 07/2021
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 07/2021
1	Interleukin-22 (IL-22)IBA 01/2020
1	Uric Acid (Urate)IBA 01/2020
1	Interleukin-1 (Interleukin 1)IBA 01/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Complement System Proteins (Complement)IBA 10/2016
1	Tamoxifen FDA LinkGeneric 10/2016
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 10/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2015
1	Interferon Type IIBA 10/2014
1	DigA16IBA 09/2012
1	Immunoglobulin M (IgM)IBA 07/2012
1	Immunoconjugates (Immunoconjugate)IBA 07/2012
1	AntigensIBA 12/2004

Therapy/Procedure

2	Radiotherapy 07/2021 - 03/2009
2	Therapeutics 10/2014 - 03/2009
1	Hematopoietic Stem Cell Transplantation 01/2019
1	Radioimmunotherapy 07/2012
1	Immunotherapy 12/2004